Baloramotide
Term · Oncology and biomedicine · MLC-T-ONC-011870
A genetically engineered synthetic protein, recombinant NY-ESO-1 protein (cancer-testis tumor antigen family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.
| Identifier | MLC-T-ONC-011870 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cancer/testis antigen 1, recombinant; recombinant NY-ESO-1 protein |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011870",
"term": "Baloramotide",
"field": "Oncology and biomedicine",
"definition": "A genetically engineered synthetic protein, recombinant NY-ESO-1 protein (cancer-testis tumor antigen family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.",
"synonyms": [
"cancer/testis antigen 1, recombinant",
"recombinant NY-ESO-1 protein"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/baloramotide/"
}
Record 3,266 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.